Low dosecytokines, hormones, and growth factors create new scenarios in the treatment of a large number of diseases.
15 years of expertise in the low dose field have led to a critical mass of clinical trials that validate the effectiveness of this new pharmacological paradigm.
Advanced Therapies
Rapidly Progressive Periodontitis (RPP) with interleukin-10 polymorphism and concomitant systemic diseases. Standard overlapping treatment with a Low-Dose SKA medicine. Spontaneous retrospective observation.
Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis